Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
12 studies found for:    "West Nile Fever"
Show Display Options
RSS Create an RSS feed from your search for:
"West Nile Fever"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated
Has Results
Treatment of West Nile Virus With MGAWN1
Conditions: West Nile Neuroinvasive Disease;   West Nile Virus Infection;   Encephalitis;   Meningitis;   Acute Flaccid Paralysis;   West Nile Fever
Interventions: Biological: MGAWN1;   Biological: Placebo - normal saline
2 No longer available Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental Exposure
Condition: West Nile Virus Infection
Intervention: Biological: MGAWN1
3 Terminated An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease
Condition: West Nile Fever
Intervention: Drug: AVI-4020 Injection
4 Completed Phase I Study of West Nile Virus Vaccine
Condition: West Nile Fever
Intervention: Drug: VRC-WNVDNA020-00-VP
5 Completed Vaccine to Prevent West Nile Virus Disease
Conditions: Healthy;   West Nile Fever;   Healthy Volunteer;   HV
Intervention: Drug: VRC-WNVDNA017-00-VP
6 Completed
Has Results
Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults
Condition: West Nile Fever
Interventions: Biological: ChimeriVax-WN02 vaccine;   Biological: Placebo
7 Completed
Has Results
Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults
Condition: West Nile Fever
Interventions: Biological: ChimeriVax-WN02 Low Dose;   Biological: ChimeriVax-WN02 Medium Dose;   Biological: ChimeriVax-WN02 High Dose;   Biological: 0.9% Saline solution;   Biological: 0.9 % NaCl solution
8 Completed Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults
Condition: West Nile Fever
Interventions: Biological: WN/DEN4delta30 vaccine;   Biological: Placebo
9 Completed Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults
Condition: West Nile Fever Encephalitis
Interventions: Biological: WN/DEN4-3'delta30;   Biological: Placebo
10 Completed Natural History of West Nile Virus Infection
Conditions: West Nile Virus;   Encephalitis;   Myelitis
Intervention:
11 Recruiting Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age
Condition: West Nile Virus
Interventions: Biological: WN/DEN4Δ30 Vaccine;   Biological: Placebo
12 Completed West Nile Virus Natural History
Condition: West Nile Virus
Intervention:

Indicates status has not been verified in more than two years